Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Hamostaseologie
|
December 7, 2007
[Factor Xa-inhibition in interventional cardiology]
I Ahrens, K Peter, C Bode
Panminerva Medica
|
January 13, 2016
Asymptomatic atrial fibrillation and risk of stroke
P Stachon, I Ahrens, T Faber, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 2, 2006
A novel functional role for the highly conserved alpha-subunit KVGFFKR motif distinct from integrin alphaIIbbeta3 activation processes
K Aylward, G Meade, I Ahrens, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 1, 1972
[Alanine aminopeptidase in urine in renal diseases]
J E Peters, E Mampel, I Schneider, et al.
International Journal of Cardiology
|
March 7, 2018
Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction
S Robinson, M Follo, D Haenel, et al.
International Journal of Cardiology
|
June 13, 2017
Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction
M Hortmann, S Robinson, M Mohr, et al.
International Journal of Cardiology
|
November 11, 2017
Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury
M Hortmann, S Robinson, M Mohr, et al.
The Journal of International Medical Research
|
November 26, 2019
Influence of extracorporeal membrane oxygenation on serum microRNA expression
M Scettri, H Seeba, D L Staudacher, et al.
Basic Research in Cardiology
|
May 13, 2011
Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells
I Ahrens, H Domeij, S U Eisenhardt, et al.
ESMO Open
|
September 5, 2021
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study
K Klinghammer, J Fayette, A Kawecki, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Hamostaseologie
|
December 7, 2007
[Factor Xa-inhibition in interventional cardiology]
I Ahrens, K Peter, C Bode
Panminerva Medica
|
January 13, 2016
Asymptomatic atrial fibrillation and risk of stroke
P Stachon, I Ahrens, T Faber, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 2, 2006
A novel functional role for the highly conserved alpha-subunit KVGFFKR motif distinct from integrin alphaIIbbeta3 activation processes
K Aylward, G Meade, I Ahrens, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 1, 1972
[Alanine aminopeptidase in urine in renal diseases]
J E Peters, E Mampel, I Schneider, et al.
International Journal of Cardiology
|
March 7, 2018
Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction
S Robinson, M Follo, D Haenel, et al.
International Journal of Cardiology
|
June 13, 2017
Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction
M Hortmann, S Robinson, M Mohr, et al.
International Journal of Cardiology
|
November 11, 2017
Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury
M Hortmann, S Robinson, M Mohr, et al.
The Journal of International Medical Research
|
November 26, 2019
Influence of extracorporeal membrane oxygenation on serum microRNA expression
M Scettri, H Seeba, D L Staudacher, et al.
Basic Research in Cardiology
|
May 13, 2011
Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells
I Ahrens, H Domeij, S U Eisenhardt, et al.
ESMO Open
|
September 5, 2021
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study
K Klinghammer, J Fayette, A Kawecki, et al.
Page
of 3